# Biolargo, Inc.: Form 8-K, filed May 18, 2023

- Company: [Biolargo, Inc.](/companies/blgo.md) (CIK 880242)
- Form: 8-K
- Filed: 2023-05-18
- Accepted by EDGAR: May 18, 2023, 16:56 ET
- Period: 2023-05-18
- Accession: 0001437749-23-015141
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/880242/000143774923015141/blgo20230518_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/880242/000143774923015141/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/880242/000143774923015141/blgo20230518_8k.htm

Filed May 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-015141. Last ingested by Listed: Nov 2, 2026, 06:21 ET. No prices; not investment advice.